Real-time enrollment status for this c3 glomerulopathy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT04817618 |
| Recruiting Status | Recruiting |
| Condition | C3 Glomerulopathy |
| Phase | Clinical Trial |
| Target Enrollment | 98 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | March 4, 2025 (Mar 4, 2025) |
As of March 2, 2026: Clinical trial NCT04817618 is currently recruiting participants. This clinical trial study for c3 glomerulopathy is actively seeking new participants at 9 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04817618 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04817618 was last updated Mar 4, 2025 (March 4, 2025). HelloStudys verifies this status automatically.